Gentherm Reports Mixed 2025 Financials, Cautious 2026 Guidance, and Reiterates Modine Acquisition Details
summarizeSummary
Gentherm reported record 2025 revenue but a substantial decline in GAAP net income and EPS, alongside cautious 2026 guidance, while reaffirming its strategic acquisition of Modine's Performance Technologies business.
check_boxKey Events
-
Mixed 2025 Financial Performance
Gentherm achieved record annual revenue of $1.5 billion, but reported a significant drop in GAAP net income to $18.3 million for 2025, down from $64.9 million in 2024, with diluted EPS falling to $0.59 from $2.06.
-
Cautious 2026 Guidance and 2027 Outlook
The company provided cautious 2026 revenue guidance of $1.5 billion to $1.6 billion (approximately 3% growth ex-FX) and projected adjusted EBITDA margin expansion of ~30 basis points, with a preliminary 2027 revenue outlook of ~$1.7 billion.
-
Modine Acquisition Update
The presentation reiterated the definitive agreement to acquire Modine's Performance Technologies business, highlighting the creation of a $2.6 billion thermal and flow management leader with approximately $25 million in identified annual cost synergies, expected to close by the end of 2026.
auto_awesomeAnalysis
This 425 filing provides the detailed presentation slides for Gentherm's fourth quarter and full year 2025 earnings call, offering crucial context to the concurrent 8-K and 10-K filings. While the company achieved record annual revenue, a significant drop in GAAP net income and diluted EPS for 2025, coupled with cautious 2026 guidance, presents a mixed financial picture. However, the presentation also reiterates the strategic importance of the Modine Performance Technologies acquisition, outlining its transformational impact, identified synergies, and long-term growth trajectory. Investors should weigh the short-term financial headwinds against the potential strategic benefits of the acquisition.
At the time of this filing, THRM was trading at $31.31 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $954.5M. The 52-week trading range was $22.75 to $39.48. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.